Report Scope & Overview:
CAR T-Cell Therapy Agents Market Overview:
Global CAR T-Cell Therapy Agents Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. CAR T-Cell Therapy Agents Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Global CAR T-Cell Therapy Agents Market: By Company
• Novartis
• Gilead Sciences
• Bristol-Myers Squibb
• J & J
• JW Therapeutics
• FOSUNKite
• CARsgen Therapeutics (Pipeline)
• CARsgen Therapeutics
• Autolus Therapeutics
• Sorrento Therapeutics
• Mustang Bio
• Bluebird Bio
• Cellectis
• Allogene Therapeutics
• Celyad
Global CAR T-Cell Therapy Agents Market: By Type
• CD19-targeted
• BCMA-targeted
Global CAR T-Cell Therapy Agents Market: By Application
• Lymphoma
• Multiple Myeloma
Global CAR T-Cell Therapy Agents Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global CAR T-Cell Therapy Agents market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Reasons to Purchase CAR T-Cell Therapy Agents Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of CAR T-Cell Therapy Agents Market Study:
The objectives of CAR T-Cell Therapy Agents market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of CAR T-Cell Therapy Agents market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Global CAR T-Cell Therapy Agents Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. CAR T-Cell Therapy Agents Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
CAR T-Cell Therapy Agents Market Key Trends
Expanded Indications: Research is ongoing to expand the use of CAR T-cell therapy beyond hematological malignancies (leukemia and lymphoma) to solid tumors. Efforts are focused on developing CAR T-cell therapies for a broader range of cancer types.
Next-Generation CAR Constructs: Advances in CAR T-cell design, including next-generation CAR constructs, aim to improve the specificity, efficacy, and safety of these therapies. This involves optimizing the design of CARs to enhance tumor targeting and T-cell function.
Dual Targeting and Combinatorial Approaches: Strategies involving dual targeting, where CAR T cells are designed to recognize multiple antigens, and combinatorial approaches, combining CAR T-cell therapy with other treatment modalities like checkpoint inhibitors, are being explored for enhanced efficacy.
Allogeneic CAR T-Cell Therapies: Development of off-the-shelf or allogeneic CAR T-cell therapies, derived from healthy donor cells rather than the patient's own cells, is an area of active research. This could simplify and expedite treatment.
Cytokine Release Syndrome (CRS) Management: Research is focused on refining the management of side effects, particularly cytokine release syndrome (CRS), associated with CAR T-cell therapy. Strategies aim to mitigate these side effects while maintaining therapeutic efficacy.
Market Segmentations:Global CAR T-Cell Therapy Agents Market: By Company
• Novartis
• Gilead Sciences
• Bristol-Myers Squibb
• J & J
• JW Therapeutics
• FOSUNKite
• CARsgen Therapeutics (Pipeline)
• CARsgen Therapeutics
• Autolus Therapeutics
• Sorrento Therapeutics
• Mustang Bio
• Bluebird Bio
• Cellectis
• Allogene Therapeutics
• Celyad
Global CAR T-Cell Therapy Agents Market: By Type
• CD19-targeted
• BCMA-targeted
Global CAR T-Cell Therapy Agents Market: By Application
• Lymphoma
• Multiple Myeloma
Global CAR T-Cell Therapy Agents Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global CAR T-Cell Therapy Agents market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
| Report Attribute/Metric | Details |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • CD19-targeted • BCMA-targeted |
| By Application | • Lymphoma • Multiple Myeloma |
| Key Companies Profiled | • Novartis • Gilead Sciences • Bristol-Myers Squibb • J & J • JW Therapeutics • FOSUNKite • CARsgen Therapeutics (Pipeline) • CARsgen Therapeutics • Autolus Therapeutics • Sorrento Therapeutics • Mustang Bio • Bluebird Bio • Cellectis • Allogene Therapeutics • Celyad |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase CAR T-Cell Therapy Agents Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of CAR T-Cell Therapy Agents Market Study:
The objectives of CAR T-Cell Therapy Agents market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of CAR T-Cell Therapy Agents market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Frequently Asked Questions
TABLE OF CONTENT
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Therapy Agents Market Size Growth Rate by Type: 2017 VS 2022 VS 2032
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global CAR T-Cell Therapy Agents Market Growth by Application: 2017 VS 2022 VS 2032
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Therapy Agents Market Perspective (2017-2032)
2.2 CAR T-Cell Therapy Agents Growth Trends by Region
2.2.1 Global CAR T-Cell Therapy Agents Market Size by Region: 2017 VS 2022 VS 2032
2.2.2 CAR T-Cell Therapy Agents Historic Market Size by Region (2017-2023)
2.2.3 CAR T-Cell Therapy Agents Forecasted Market Size by Region (2023-2032)
2.3 CAR T-Cell Therapy Agents Market Dynamics
2.3.1 CAR T-Cell Therapy Agents Industry Trends
2.3.2 CAR T-Cell Therapy Agents Market Drivers
2.3.3 CAR T-Cell Therapy Agents Market Challenges
2.3.4 CAR T-Cell Therapy Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Therapy Agents Players by Revenue
3.1.1 Global Top CAR T-Cell Therapy Agents Players by Revenue (2017-2023)
3.1.2 Global CAR T-Cell Therapy Agents Revenue Market Share by Players (2017-2023)
3.2 Global CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Therapy Agents Revenue
3.4 Global CAR T-Cell Therapy Agents Market Concentration Ratio
3.4.1 Global CAR T-Cell Therapy Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Agents Revenue in 2022
3.5 CAR T-Cell Therapy Agents Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Therapy Agents Product Solution and Service
3.7 Date of Enter into CAR T-Cell Therapy Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Therapy Agents Breakdown Data by Type
4.1 Global CAR T-Cell Therapy Agents Historic Market Size by Type (2017-2023)
4.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Type (2023-2032)
5 CAR T-Cell Therapy Agents Breakdown Data by Application
5.1 Global CAR T-Cell Therapy Agents Historic Market Size by Application (2017-2023)
5.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America CAR T-Cell Therapy Agents Market Size (2017-2032)
6.2 North America CAR T-Cell Therapy Agents Market Growth Rate by Country: 2017 VS 2022 VS 2032
6.3 North America CAR T-Cell Therapy Agents Market Size by Country (2017-2023)
6.4 North America CAR T-Cell Therapy Agents Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Agents Market Size (2017-2032)
7.2 Europe CAR T-Cell Therapy Agents Market Growth Rate by Country: 2017 VS 2022 VS 2032
7.3 Europe CAR T-Cell Therapy Agents Market Size by Country (2017-2023)
7.4 Europe CAR T-Cell Therapy Agents Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Therapy Agents Market Size (2017-2032)
8.2 Asia-Pacific CAR T-Cell Therapy Agents Market Growth Rate by Region: 2017 VS 2022 VS 2032
8.3 Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2017-2023)
8.4 Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR T-Cell Therapy Agents Market Size (2017-2032)
9.2 Latin America CAR T-Cell Therapy Agents Market Growth Rate by Country: 2017 VS 2022 VS 2032
9.3 Latin America CAR T-Cell Therapy Agents Market Size by Country (2017-2023)
9.4 Latin America CAR T-Cell Therapy Agents Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Therapy Agents Market Size (2017-2032)
10.2 Middle East & Africa CAR T-Cell Therapy Agents Market Growth Rate by Country: 2017 VS 2022 VS 2032
10.3 Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2017-2023)
10.4 Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis CAR T-Cell Therapy Agents Introduction
11.1.4 Novartis Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences CAR T-Cell Therapy Agents Introduction
11.2.4 Gilead Sciences Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Introduction
11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J CAR T-Cell Therapy Agents Introduction
11.4.4 J & J Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Detail
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics CAR T-Cell Therapy Agents Introduction
11.5.4 JW Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Detail
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite CAR T-Cell Therapy Agents Introduction
11.6.4 FOSUNKite Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Detail
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Detail
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Detail
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Introduction
11.9.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.9.5 Autolus Therapeutics Recent Development
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Detail
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Introduction
11.10.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.10.5 Sorrento Therapeutics Recent Development
11.11 Mustang Bio
11.11.1 Mustang Bio Company Detail
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio CAR T-Cell Therapy Agents Introduction
11.11.4 Mustang Bio Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.11.5 Mustang Bio Recent Development
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Detail
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio CAR T-Cell Therapy Agents Introduction
11.12.4 Bluebird Bio Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.12.5 Bluebird Bio Recent Development
11.13 Cellectis
11.13.1 Cellectis Company Detail
11.13.2 Cellectis Business Overview
11.13.3 Cellectis CAR T-Cell Therapy Agents Introduction
11.13.4 Cellectis Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.13.5 Cellectis Recent Development
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Detail
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Introduction
11.14.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.14.5 Allogene Therapeutics Recent Development
11.15 Celyad
11.15.1 Celyad Company Detail
11.15.2 Celyad Business Overview
11.15.3 Celyad CAR T-Cell Therapy Agents Introduction
11.15.4 Celyad Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.15.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Therapy Agents Market Size Growth Rate by Type: 2017 VS 2022 VS 2032
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global CAR T-Cell Therapy Agents Market Growth by Application: 2017 VS 2022 VS 2032
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Therapy Agents Market Perspective (2017-2032)
2.2 CAR T-Cell Therapy Agents Growth Trends by Region
2.2.1 Global CAR T-Cell Therapy Agents Market Size by Region: 2017 VS 2022 VS 2032
2.2.2 CAR T-Cell Therapy Agents Historic Market Size by Region (2017-2023)
2.2.3 CAR T-Cell Therapy Agents Forecasted Market Size by Region (2023-2032)
2.3 CAR T-Cell Therapy Agents Market Dynamics
2.3.1 CAR T-Cell Therapy Agents Industry Trends
2.3.2 CAR T-Cell Therapy Agents Market Drivers
2.3.3 CAR T-Cell Therapy Agents Market Challenges
2.3.4 CAR T-Cell Therapy Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Therapy Agents Players by Revenue
3.1.1 Global Top CAR T-Cell Therapy Agents Players by Revenue (2017-2023)
3.1.2 Global CAR T-Cell Therapy Agents Revenue Market Share by Players (2017-2023)
3.2 Global CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Therapy Agents Revenue
3.4 Global CAR T-Cell Therapy Agents Market Concentration Ratio
3.4.1 Global CAR T-Cell Therapy Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Agents Revenue in 2022
3.5 CAR T-Cell Therapy Agents Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Therapy Agents Product Solution and Service
3.7 Date of Enter into CAR T-Cell Therapy Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Therapy Agents Breakdown Data by Type
4.1 Global CAR T-Cell Therapy Agents Historic Market Size by Type (2017-2023)
4.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Type (2023-2032)
5 CAR T-Cell Therapy Agents Breakdown Data by Application
5.1 Global CAR T-Cell Therapy Agents Historic Market Size by Application (2017-2023)
5.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America CAR T-Cell Therapy Agents Market Size (2017-2032)
6.2 North America CAR T-Cell Therapy Agents Market Growth Rate by Country: 2017 VS 2022 VS 2032
6.3 North America CAR T-Cell Therapy Agents Market Size by Country (2017-2023)
6.4 North America CAR T-Cell Therapy Agents Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Agents Market Size (2017-2032)
7.2 Europe CAR T-Cell Therapy Agents Market Growth Rate by Country: 2017 VS 2022 VS 2032
7.3 Europe CAR T-Cell Therapy Agents Market Size by Country (2017-2023)
7.4 Europe CAR T-Cell Therapy Agents Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Therapy Agents Market Size (2017-2032)
8.2 Asia-Pacific CAR T-Cell Therapy Agents Market Growth Rate by Region: 2017 VS 2022 VS 2032
8.3 Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2017-2023)
8.4 Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR T-Cell Therapy Agents Market Size (2017-2032)
9.2 Latin America CAR T-Cell Therapy Agents Market Growth Rate by Country: 2017 VS 2022 VS 2032
9.3 Latin America CAR T-Cell Therapy Agents Market Size by Country (2017-2023)
9.4 Latin America CAR T-Cell Therapy Agents Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Therapy Agents Market Size (2017-2032)
10.2 Middle East & Africa CAR T-Cell Therapy Agents Market Growth Rate by Country: 2017 VS 2022 VS 2032
10.3 Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2017-2023)
10.4 Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis CAR T-Cell Therapy Agents Introduction
11.1.4 Novartis Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences CAR T-Cell Therapy Agents Introduction
11.2.4 Gilead Sciences Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Introduction
11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J CAR T-Cell Therapy Agents Introduction
11.4.4 J & J Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Detail
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics CAR T-Cell Therapy Agents Introduction
11.5.4 JW Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Detail
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite CAR T-Cell Therapy Agents Introduction
11.6.4 FOSUNKite Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Detail
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Detail
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Detail
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Introduction
11.9.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.9.5 Autolus Therapeutics Recent Development
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Detail
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Introduction
11.10.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.10.5 Sorrento Therapeutics Recent Development
11.11 Mustang Bio
11.11.1 Mustang Bio Company Detail
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio CAR T-Cell Therapy Agents Introduction
11.11.4 Mustang Bio Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.11.5 Mustang Bio Recent Development
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Detail
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio CAR T-Cell Therapy Agents Introduction
11.12.4 Bluebird Bio Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.12.5 Bluebird Bio Recent Development
11.13 Cellectis
11.13.1 Cellectis Company Detail
11.13.2 Cellectis Business Overview
11.13.3 Cellectis CAR T-Cell Therapy Agents Introduction
11.13.4 Cellectis Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.13.5 Cellectis Recent Development
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Detail
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Introduction
11.14.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.14.5 Allogene Therapeutics Recent Development
11.15 Celyad
11.15.1 Celyad Company Detail
11.15.2 Celyad Business Overview
11.15.3 Celyad CAR T-Cell Therapy Agents Introduction
11.15.4 Celyad Revenue in CAR T-Cell Therapy Agents Business (2017-2023)
11.15.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast